Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-128.01%
operating margin TTM
-113.15%
revenue TTM
44.32 Million
revenue per share TTM
7.53$
valuation ratios | |
|---|---|
| pe ratio | -0.32 |
| peg ratio | 0.02 |
| price to book ratio | -7.07 |
| price to sales ratio | 0.17 |
| enterprise value multiple | 0.29 |
| price fair value | -7.07 |
profitability ratios | |
|---|---|
| gross profit margin | 61.8% |
| operating profit margin | -113.15% |
| pretax profit margin | -128.36% |
| net profit margin | -128.01% |
| return on assets | -100.02% |
| return on equity | -2233.03% |
| return on capital employed | -311.6% |
liquidity ratios | |
|---|---|
| current ratio | 0.27 |
| quick ratio | 0.27 |
| cash ratio | 0.12 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 33.00 |
| days of payables outstanding | 97.48 |
| cash conversion cycle | -64.48 |
| receivables turnover | 11.06 |
| payables turnover | 3.74 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.47 |
| debt equity ratio | -10.41 |
| long term debt to capitalization | 1.44 |
| total debt to capitalization | 1.11 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -1.47 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.25 |
| cash per share | 0.14 |
| operating cash flow per share | -1.19 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -1.47 |
| short term coverage ratios | -2.16 |
| capital expenditure coverage ratio | -22.67 |
Frequently Asked Questions
When was the last time Vivos Therapeutics, Inc. (NASDAQ:VVOS) reported earnings?
Vivos Therapeutics, Inc. (VVOS) published its most recent earnings results on 20-05-2026.
What is Vivos Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vivos Therapeutics, Inc. (NASDAQ:VVOS)'s trailing twelve months ROE is -2233.03%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vivos Therapeutics, Inc. (VVOS) currently has a ROA of -100.02%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VVOS's net profit margin stand at?
VVOS reported a profit margin of -128.01% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VVOS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.27 in the most recent quarter. The quick ratio stood at 0.27, with a Debt/Eq ratio of -10.41.